Pre-Open Movers 04/02: (SLS) (MNOV) (CVLT) Higher; (ALKS) (SORL) (ITCI) Lower (more...)

April 2, 2018 9:21 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Today's Pre-Open Movers

SELLAS Life Sciences Group Inc., (Nasdaq: SLS) 44.9% HIGHER; announced positive interim data from the prospective, randomized, single-blinded, controlled Phase 2b independent investigator-sponsored clinical trial (IST) of trastuzumab (Herceptin®) +/- nelipepimut-S (NeuVax) in HER2 1+/2+ breast cancer patients in the adjuvant setting to prevent recurrences.

MediciNova, Inc. (NASDAQ: MNOV) 27.2% HIGHER; announced that it will terminate the Phase 2 clinical trial of MN-001 (tipelukast) in NASH (non-alcoholic steatohepatitis) and NAFLD (non-alcoholic fatty liver disease) with hypertriglyceridemia early based on the significant positive results from an interim analysis.

Alkermes plc (Nasdaq: ALKS) 19.4% LOWER; received a Refusal to File letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD) in patients with an inadequate response to standard antidepressant therapies.

Sorl Auto Parts (NASDAQ: SORL) 16.3% LOWER; reported Q4 EPS of $0.15, versus $0.47 reported last year. Revenue for the quarter came in at $123 million versus the consensus estimate of $103.59 million.

Compugen Ltd. (NASDAQ: CGEN) 12.4% HIGHER; announced it entered into an exclusive license agreement with MedImmune, the global biologics research and development arm of AstraZeneca (NYSE: AZN), to enable the development of bi-specific and multi-specific immuno-oncology antibody products.

Commvault Systems, Inc. (NASDAQ: CVLT) 9.6% HIGHER; Elliott Management disclosed a 10.3% and released a letter announcing its intention to nominate four highly qualified candidates to the Commvault Board.

Intra-Cellular Therapies (NASDAQ: ITCI) 6.9% LOWER; down on ALKS news

Humana (NYSE: HUM) 5.9% HIGHER; Walmart (NYSE: WMT) is in early states talks to buy health insurance provider Humana (NYSE: HUM), the Wall Street Journal reported late Thursday

Senseonics Holdings, Inc. (NYSE: SENS) 5.7% HIGHER; announced a favorable outcome of the U.S. Food and Drug Administration (FDA) Clinical Chemistry and Clinical Toxicology Devices meeting on the Eversense system. The panel, comprised of independent medical experts, voted unanimously, 8 to 0, that the benefits outweigh the risks, voted unanimously, 8 to 0, that the system is safe, and voted unanimously, 8 to 0, that the system is effective.

Fitbit (NYSE: FIT) 4.1% LOWER; Morgan Stanley downgraded from Equalweight to Underweight with a price target of $4.00 (from $5.00).

Tesla (NASDAQ: TSLA) 3.9% LOWER; Musk jokes about bankruptcy in a tweet, continued worries about AutoPilot and cautious ahead of Model 3 numbers.

Under Armour (NYSE: UA) (NYSE: UAA) 3.4% LOWER; says 150 million MyFitnessPal accounts breached

Amazon (NASDAQ: AMZN) 2% LOWER; President Trump escalates attacks.

Northern Trust (NASDAQ: NTRS) 1% HIGHER; Goldman Sachs upgraded from Neutral to Buy with a price target of $121.00 (from $113.00).

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Special Reports

Related Entities

Goldman Sachs, The Children's Investment Fund (TCI), Morgan Stanley, Elliott Associates, Tesla, Pre-Open Losers, Pre-Open Winners, Pre Market Movers, Model 3, FDA